Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA327589 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR3738910.fastq.gz | Fastqsanger.gz | |||
| SRR3738920.fastq.gz | Fastqsanger.gz | |||
| SRR3738930.fastq.gz | Fastqsanger.gz | |||
| SRR3738940.fastq.gz | Fastqsanger.gz | |||
| SRR3738950.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 48 |
Similar Datasets
Project description:Microarray analysis of blood of 40 sporadic Parkinson's disease patients and 20 healthy controls
2025-01-24 | E-GEOD-72267 | ExpressionAtlas
Project description:RNA-seq of blood from 105 patients with brucellosis, 17 patients with Leishmaniasis and 47 healthy controls
2025-01-24 | E-GEOD-69597 | ExpressionAtlas
Project description:Blood exsosomal miRNAs of liver disease patients
| PRJNA324589 | ENA
Project description:RNA-seq of peripheral blood from healthy controls and established relapsing-remitting multiple sclerosis patients
2025-01-24 | E-GEOD-66573 | ExpressionAtlas
Project description:RNA-seq of blood cells from 99 systemic lupus erythematosus patients and 18 healthy controls
2025-01-24 | E-GEOD-72509 | ExpressionAtlas
Project description:Transcriptional profiling of Homo sapiens inflammatory skin diseases (whole skin biospies): Psoriasis (Pso), vs Atopic Dermatitis (AD) vs Lichen planus (Li), vs Contact Eczema (KE), vs Healthy control (KO) In recent years, different genes and proteins have been highlighted as potential biomarkers for psoriasis, one of the most common inflammatory skin diseases worldwide. However, most of these markers are not psoriasis-specific but also found in other inflammatory disorders. We performed an unsupervised cluster analysis of gene expression profiles in 150 psoriasis patients and other inflammatory skin diseases (atopic dermatitis, lichen planus, contact eczema, and healthy controls). We identified a cluster of IL-17/TNFα-associated genes specifically expressed in psoriasis, among which IL-36γ was the most outstanding marker. In subsequent immunohistological analyses IL-36γ was confirmed to be expressed in psoriasis lesions only. IL-36γ peripheral blood serum levels were found to be closely associated with disease activity, and they decreased after anti-TNFα-treatment. Furthermore, IL-36γ immunohistochemistry was found to be a helpful marker in the histological differential diagnosis between psoriasis and eczema in diagnostically challenging cases. These features highlight IL-36γ as a valuable biomarker in psoriasis patients, both for diagnostic purposes and measurement of disease activity during the clinical course. Furthermore, IL-36γ might also provide a future drug target, due to its potential amplifier role in TNFα- and IL-17 pathways in psoriatic skin inflammation. In recent years, different genes and proteins have been highlighted as potential biomarkers for psoriasis, one of the most common inflammatory skin diseases worldwide. However, most of these markers are not psoriasis-specific but also found in other inflammatory disorders. We performed an unsupervised cluster analysis of gene expression profiles in 150 psoriasis patients and other inflammatory skin diseases (atopic dermatitis, lichen planus, contact eczema, and healthy controls). We identified a cluster of IL-17/TNFα-associated genes specifically expressed in psoriasis, among which IL-36γ was the most outstanding marker. In subsequent immunohistological analyses IL-36γ was confirmed to be expressed in psoriasis lesions only. IL-36γ peripheral blood serum levels were found to be closely associated with disease activity, and they decreased after anti-TNFα-treatment. Furthermore, IL-36γ immunohistochemistry was found to be a helpful marker in the histological differential diagnosis between psoriasis and eczema in diagnostically challenging cases. These features highlight IL-36γ as a valuable biomarker in psoriasis patients, both for diagnostic purposes and measurement of disease activity during the clinical course. Furthermore, IL-36γ might also provide a future drug target, due to its potential amplifier role in TNFα- and IL-17 pathways in psoriatic skin inflammation.
2014-12-02 | GSE63741 | GEO
Project description:Transcription profiling by array of of peripheral blood cells from 20 healthy controls and 20 colorectal cancer patients
2025-01-22 | E-MEXP-3756 | ExpressionAtlas
Project description:Microarray analysis of peripheral blood monocytes from patients with Alzheimer's disease or mild cognitive impairment and healthy individuals
2025-01-24 | E-GEOD-18309 | ExpressionAtlas
Project description:microRNA profiling by array of peripheral blood mononuclear cells from patients with early onset psoriatic arthritis, rheumatoid arthritis and healthy controls.
2025-01-23 | E-MTAB-3956 | ExpressionAtlas
Project description:Transcription profiling by 3'-end sequencing of whole blood from pancreatic ductal adenocarcinoma (PDAC) patients and healthy controls for PDAC diagnosis
2025-01-23 | E-MTAB-3823 | ExpressionAtlas